-
December 2, 2019PREVIEW
Data from the National Health Interview Survey published in the Annals of Internal Medicine suggest that approximately 29 million Americans are taking daily aspirin for primary prevention...
-
November 12, 2019PREVIEW
Use of dapagliflozin (Farxiga—AstraZeneca) in patients with heart failure (HF) and a reduced ejection fraction (EF) decreased the risk of worsening HF or cardiovascular (CV) death regardless of...
-
October 15, 2019PREVIEW
Stopping statins used by older patients for primary prevention was associated with an increased risk of cardiovascular (CV) adverse events such as coronary, cerebrovascular, and other vascular...
-
October 8, 2019PREVIEW
According to a retrospective analysis published in the Journal of the American Geriatrics Society, use of direct oral anticoagulants (DOACs) in older patients with nonvalvular atrial...
-
August 27, 2019PREVIEW
Use of aclidinium bromide (Tudorza Pressair—Circassia) in patients with chronic obstructive pulmonary disease (COPD) and established cardiovascular (CV) disease or CV risk factors was noninferior...
Pages
